Study identifier:D6874L00026
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Oral mucosal absorption of ICI176,334-1 in Japanese healthy male subjects
Healthy
Phase 1
Yes
ICI176,334-1
Male
8
Interventional
20 Years - 45 Years
Allocation: Non-randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
The purpose of this study is to investigate the presence or absence of oral mucosal absorption of ICI176,334-1
Oral mucosal absorption of ICI176,334-1 in Japanese healthy male subjects
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: Active 1 8 subjects will receive ICI176,334-1 | Drug: ICI176,334-1 Subject will receive single dose of ICI176,334-1 |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.